Article

Aromatase Inhibitors and Contralateral Breast Cancer in BRCA Mutation Carriers: A long-term Follow-up

2021-12-20

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Deleterious BRCA mutations confer a significant lifetime risk of breast cancer (BC) as well as contralateral BC (CBC) in patients who do not undergo prophylactic mastectomy. Prior reports have suggested that tamoxifen reduces the risk of CBC in BRCA mutation carriers. Whether aromatase inhibitors (AI) have the same effect is unknown. <bold>Methods:</bold> This i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 30bde3b3-7631-5467-baea-d2b76a5b075d
DOI: 10.21203/rs.3.rs-1158051/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Aromatase Inhibitors and Contralateral Breast Cancer in BRCA Mutation Carriers: A long-term Follow-upDOI 10.21203/rs.3.rs-1158051/v1Read

Aromatase inhibitors and contralateral breast cancer in BRCA mutation carriers.Semantic proximity Read

Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study.Semantic proximity Read

Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.Semantic proximity Read

Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis.Semantic proximity Read

Breast cancer surveillance following ovarian cancer in BRCA mutation carriers.Semantic proximity Read

Does bilateral mastectomy affect clinical outcomes in BRCA1/2 mutation carriers with primary breast cancer? A systematic review and meta-analysis.Semantic proximity Read

Combined breast conservation therapy versus mastectomy for BRCA mutation carriers - A systematic review and meta-analysis.Semantic proximity Read

BRCA Mutation Testing in Determining Breast Cancer TherapySemantic proximity Read

Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation.Semantic proximity Read

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read

Breast cancer prevention in high-risk women.Semantic proximity Read

Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age.Semantic proximity Read